Merkel cell cancer screening: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
Line 3: Line 3:
{{CMG}} ; {{AE}} {{VKG}} {{AAM}}
{{CMG}} ; {{AE}} {{VKG}} {{AAM}}
==Overview==
==Overview==
According to the [[United states preventive services task force recommendations scheme]] ([[United states preventive services task force recommendations scheme|USPSTF]]), there is insufficient evidence to recommend routine [[Screening (medicine)|screening]] for [[skin cancers]], including [[merkel cell cancer]].
According to the [[United states preventive services task force recommendations scheme]] ([[United states preventive services task force recommendations scheme|USPSTF]]), there is insufficient evidence to recommend routine [[Screening (medicine)|screening]] for [[skin cancers]], including merkel cell cancer.
==Screening==
==Screening==
According to the [[United states preventive services task force recommendations scheme]] ([[United states preventive services task force recommendations scheme|USPSTF]]), there is insufficient evidence to recommend routine [[Screening (medicine)|screening]] for [[skin cancers]], including [[merkel cell cancer]].<ref name="pmid12522368">{{cite journal |vauthors=Geller AC, Zhang Z, Sober AJ, Halpern AC, Weinstock MA, Daniels S, Miller DR, Demierre MF, Brooks DR, Gilchrest BA |title=The first 15 years of the American Academy of Dermatology skin cancer screening programs: 1985-1999 |journal=J. Am. Acad. Dermatol. |volume=48 |issue=1 |pages=34–41 |date=January 2003 |pmid=12522368 |doi=10.1067/mjd.2003.9 |url=}}</ref>
According to the [[United states preventive services task force recommendations scheme]] ([[United states preventive services task force recommendations scheme|USPSTF]]), there is insufficient evidence to recommend routine [[Screening (medicine)|screening]] for [[skin cancers]], including merkel cell cancer.<ref name="pmid12522368">{{cite journal |vauthors=Geller AC, Zhang Z, Sober AJ, Halpern AC, Weinstock MA, Daniels S, Miller DR, Demierre MF, Brooks DR, Gilchrest BA |title=The first 15 years of the American Academy of Dermatology skin cancer screening programs: 1985-1999 |journal=J. Am. Acad. Dermatol. |volume=48 |issue=1 |pages=34–41 |date=January 2003 |pmid=12522368 |doi=10.1067/mjd.2003.9 |url=}}</ref>


==References==
==References==

Latest revision as of 02:28, 31 January 2019

Merkel cell cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Merkel Cell Cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

CT

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Merkel cell cancer screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Merkel cell cancer screening

All Images
X-rays
Echo and Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Merkel cell cancer screening

CDC on Merkel cell cancer screening

Merkel cell cancer screening in the news

Blogs on Merkel cell cancer screening

Directions to Hospitals Treating Merkel cell cancer

Risk calculators and risk factors for Merkel cell cancer screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Vamsikrishna Gunnam M.B.B.S [2] Ahmad Al Maradni, M.D. [3]

Overview

According to the United states preventive services task force recommendations scheme (USPSTF), there is insufficient evidence to recommend routine screening for skin cancers, including merkel cell cancer.

Screening

According to the United states preventive services task force recommendations scheme (USPSTF), there is insufficient evidence to recommend routine screening for skin cancers, including merkel cell cancer.[1]

References

  1. Geller AC, Zhang Z, Sober AJ, Halpern AC, Weinstock MA, Daniels S, Miller DR, Demierre MF, Brooks DR, Gilchrest BA (January 2003). "The first 15 years of the American Academy of Dermatology skin cancer screening programs: 1985-1999". J. Am. Acad. Dermatol. 48 (1): 34–41. doi:10.1067/mjd.2003.9. PMID 12522368.